ziftomenib,Venetoclax,Azacitidine,Daunorubicin,Cytarabine
kura oncology,Roche,Abbvie
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'ziftomenib']
dr. fathi et al. late breaking abstract. ziftomenib in r/r npm1-mutated aml is well tolerated, with no drug induced qtc and manageable ds; the lack of predicted adverse drug-drug interactions is supportive of combination approaches. #eha2023 #amlsm #leusm 
Senior researcher (@IKNL, @ErasmusMC, @AmsterdamUMC) leading population-based cancer research in the Netherlands. Tweets are my own. #leusm #lymsm #crypto #xrp